Comparing the effects of high-dose vitamin E with those of placebo on insulin resistance in patients with schizophrenia treated with olanzapine.
Salmasi
Fiona Baroyant
FB
Jazayeri
Maryam
M
Ghaeli
Padideh
P
Hashemian
Farshad
F
Akhondzadeh
Shahin
S
Raisi
Firoozeh
F
Hosseini
Seyed Hamzeh
SH
Setareh
Mohammad Javad
MJ
Khavidaki
Simin Dashti
SD
D000293:Adolescent; D000328:Adult; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000187:drug effects; D004311:Double-Blind Method; D006442:Glycated Hemoglobin / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D008875:Middle Aged; D000077152:Olanzapine; D018384:Oxidative Stress / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy; D055815:Young Adult; D024502:alpha-Tocopherol / Q000494:pharmacology / Q000627:therapeutic use*
D000975:Antioxidants; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007328:Insulin; D000077152:Olanzapine; D024502:alpha-Tocopherol